Thermo Fisher Scientific Inc. ($TMO) has been witnessing notable activity in asset management with multiple purchases of its stock. Firms like Raiffeisen Bank International AG, First National Bank of Omaha, NEOS Investment Management LLC, and Vanguard Group Inc. have increased their holdings significantly. Tredje AP fonden sold a considerable amount of TMO''s shares. The stock has been facing recent pullbacks, prompting questions about its intrinsic value. Questions also arose concerning TMO's pricing considering its recent share pullback and DCF estimate. HighTower Advisors LLC, Mondrian Investment Partners LTD, and Assetmark Inc have also purchased shares.However, TMO also faced challenges, with Q2 trading lower and its 2026 profit forecast falling below estimates due to research funding cuts. Its Q4 earnings and revenue estimates were beaten, and significant revenue growth was highlighted in its Q4 earnings call. Looking ahead, the company is leveraging real-world data interoperability and establishing strategic collaboration with Datavant.
Thermo Fisher Scientific TMO News Analytics from Wed, 23 Jul 2025 07:00:00 GMT to Sat, 21 Feb 2026 13:57:07 GMT -
Rating 6
- Innovation 5
- Information 7
- Rumor 4
